Julia P. Gregory
Director · Nurix Therapeutics, Inc.
Individual
- 2025
- May 15, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Julia P. Gregory files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John W. Childs - $25.86M in BHVN purchases and sales in the last 12 months
- Vlad Coric - $5.00M in BHVN purchases and sales in the last 12 months
- Christine Ring - $3.33M in NRIX purchases and sales in the last 12 months
- Gregory Bailey - $3.00M in BHVN purchases and sales in the last 12 months
- Houte Hans van - $635K in NRIX purchases and sales in the last 12 months
- Gwenn Hansen - $522K in NRIX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Julia P. Gregory?
Julia P. Gregory is a corporate insider, tracked as Director of Nurix Therapeutics, Inc. (NRIX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Julia P. Gregory last file a Form 4?
The most recent primary Form 4 on record is dated 15 May 2026, one of 5 filings going back to 2025.
